Levoxyl and Ginkgo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levoxyl (levothyroxine sodium) and Ginkgo (ginkgo). Common drug interactions include fatigue among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Levoxyl and Ginkgo. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Ginkgo?

Ginkgo has active ingredients of ginkgo. It is often used in memory loss. eHealthMe is studying from 4,473 Ginkgo users. Check the latest studies of Ginkgo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

28 people who take Levoxyl and Ginkgo together, and have interactions are studied.

What are the common drug interactions of Levoxyl and Ginkgo, by gender? *:

female:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Hypoacusis (loss of hearing)
Anxiety
Constipation
Injury
Nausea (feeling of having an urge to vomit)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Synovial cyst (cyst of joint filled with synovial fluid)
Contusion (a type of hematoma of tissue in which capillaries)

male:

Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Visual impairment

What are the common drug interactions of Levoxyl and Ginkgo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Decreased appetite
Dependence
Disturbance in attention
Eating disorder
Emotional distress
Gastritis (inflammation of stomach)
Hepatic steatosis (fatty liver disease)
Hospitalisation
Hypersomnia (excessive daytime sleepiness (eds))
Illusion

50-59:

Psoriasis (immune-mediated disease that affects the skin)

60+:

Macular fibrosis (a thin sheet of scar tissue forms on top of the macula, in response to damage or injury)
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Fatigue (feeling of tiredness)
Asthenia (weakness)
Discomfort
Weight decreased
Agitation (state of anxiety or nervous excitement)
Anxiety
Aphthous stomatitis (mouth ulcer)
Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)

What are the existing conditions these people have? *

Constipation: 7 people, 25.00%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 6 people, 21.43%
Pain: 6 people, 21.43%
Bladder Spasm: 6 people, 21.43%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 6 people, 21.43%
Multiple Myeloma (cancer of the plasma cells): 6 people, 21.43%
Spinal Disorder (disease of spine a back bone): 6 people, 21.43%
Diarrhea: 6 people, 21.43%
High Blood Cholesterol: 5 people, 17.86%
Thyroid Diseases: 4 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and Ginkgo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously